Effects of Microengineered Interactions on Liver-Specific Gene Expression
Effects of Microengineered Interactions on Liver-Specific Gene Expression
批准号:
7273888
负责人:
Alexander Revzin
金额:
$17.95万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-01 至 2008-07-31
关键词:
AdhesivesAlbuminsArtificial LiverBiologicalBiologyCell CommunicationCell CountCell LineCell TherapyCell surfaceCellsCoculture TechniquesCollecting CellComplementConditionCultured CellsDevelopmentDevicesEngineeringEnvironmentExtracellular MatrixFamily suidaeFutureGene ExpressionGenesGlassHepaticHepatocyteHumanHuman EngineeringHydrogelsIncubatedInvestmentsLinkLiverMessenger RNAMethodsMicrofabricationMonitorMusNumbersPhenotypePopulationPrintingProtein ArrayProtein BiosynthesisProtein C InhibitorProteinsResearchReverse Transcriptase Polymerase Chain ReactionRoboticsSeedsSlideSorting - Cell MovementSourceStaining methodStainsStandards of Weights and MeasuresStem cellsStimulusSubstrate InteractionSurfaceTechnologyTimeTransferrinUp-Regulationalpha 1-Antitrypsinbasecell typedesignembryonic stem cellfetalhazardhuman TERT proteinhuman embryonic stem celllaser capture microdissectionnovelnovel strategiesreconstitutionresearch studystemtelomerase reverse transcriptasetooltrend
中文摘要
描述(由申请人提供):肝脏生物学方面的大量研究工作集中在为肝脏定向细胞疗法、生物人工肝辅助设备和其他应用寻找新的肝细胞来源。重点是研究祖细胞、胎肝细胞或人类胚胎干细胞(ESC);这些细胞可以首先扩增,然后被诱导表达肝脏特异性功能。最近,我们建立了一种新型的基因工程人胎肝细胞系,该细胞系含有重组的人端粒酶逆转录酶(HTERT)亚单位,能够进行300多个细胞倍增。传统的细胞培养方法一次一个地改变生物诱导剂,需要大量的细胞和大量的时间投资来进行彻底的分析。这些方法不适合于确定在新的胎儿或干细胞来源的细胞系中诱导肝脏表型所需的微环境的精确组成。在这里,我们建议使用基于微制造和微阵列的细胞培养方法,以允许在精确定义的微环境条件下培养小群细胞,并同时暴露于多种生物刺激。这些新的细胞培养工具将通过提供适当的细胞-细胞和细胞-细胞外基质(ECM)相互作用的组合,在永生化的胎肝细胞中诱导肝脏特异性分化。建议的细胞培养平台将补充一种新的方法,在当地环境的背景下评估肝功能。激光捕获显微切割将与实时定量RT-PCR相结合,从局部工程微环境中提取小群肝细胞,并分析肝脏特异基因的表达。白蛋白、转铁蛋白和α1-抗胰蛋白酶等基因的上调将确认给定的生物刺激组合对肝脏分化具有积极影响。在未来,所提出的微制造装置将被用于诱导人胚胎干细胞向肝系分化。
英文摘要
DESCRIPTION (provided by applicant): Considerable research efforts in liver biology are focused on deriving new sources of hepatocytes for liver directed cell therapies, bioartificial liver-assist devices and other applications. Emphasis is being placed on investigating progenitor cells, fetal hepatocytes or human embryonic stem cells (ESC); cells that could first be expanded and then induced to express liver-specific function. Recently, we developed a novel genetically-engineered human fetal hepatocyte cell line containing reconstituted human telomerase reverse transcriptase (hTERT) subunits and capable of more than 300 cell doublings. Traditional cell culture approaches vary biological inducers one-at-a-time, requiring large number of cells and considerable time investment for thorough analysis. These methods are not well suited for defining precise composition of the microenvironment required to induce hepatic phenotype in novel, fetal- or stem cell-derived cell lines. Here we propose to employ microfabrication- and microarraying-based cell culture approaches to allow for small groups of cells to be cultured under precisely-defined microenvironment conditions and to be exposed to multiple biological stimuli in parallel. These novel cell culture tools will be applied to induce liver-specific differentiation in the immortalized fetal hepatocytes by providing an appropriate combination of the cell-cell and cell-extracellular matrix (ECM) interactions. Proposed cell culture platforms will be complemented with a new approach for evaluating hepatic function in the context of the local environment. Laser capture microdissection will be used in tandem with real-time quantitative RT-PCR to retrieve small groups of hepatic cells from locally engineered microenvironment and to analyze expression of liver specific genes. Upregulation in such genes as albumin, transferrin and alpha 1-antitrypsin will indentify a given combination of biological stimuli as having a positive effect on hepatic differentiation. In the future, proposed microfabricated devices will be used to induce differentiation of human ESC toward hepatic lineage.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1089/ten.tea.2012.0681
发表时间:
2013-08
期刊:
Tissue engineering. Part A
影响因子:
--
作者:
[Jungmok You;Sua Park;Dong-Sik Shin;Dipali Patel;V. K. Raghunathan;Mihye Kim;C. Murphy;G. Tae]
通讯作者:
Jungmok You;Sua Park;Dong-Sik Shin;Dipali Patel;V. K. Raghunathan;Mihye Kim;C. Murphy;G. Tae
DOI:
10.1371/journal.pone.0112698
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Gao W, Zhou P, Ma X, Tschudy-Seney B, Chen J, Magner NL, Revzin A, Nolta JA, Zern MA, Duan Y]
通讯作者:
Duan Y
Multilayered heparin hydrogel microwells for cultivation of primary hepatocytes.
多层肝素水凝胶微孔用于培养原发性肝细胞。
DOI:
10.1002/adhm.201300054
发表时间:
2014-01
期刊:
ADVANCED HEALTHCARE MATERIALS
影响因子:
10
作者:
[You, Jungmok, Shin, Dong-Sik, Patel, Dipali, Gao, Yandong, Revzin, Alexander]
通讯作者:
Revzin, Alexander
DOI:
10.1016/j.biomaterials.2010.04.006
发表时间:
2010-08
期刊:
BIOMATERIALS
影响因子:
14
作者:
[Jones, Caroline N., Tuleuova, Nazgul, Lee, Ji Youn, Ramanculov, Erlan, Reddi, A. Hari, Zern, Mark A., Revzin, Alexander]
通讯作者:
Revzin, Alexander
DOI:
10.1016/j.biomaterials.2010.08.050
发表时间:
2010-12
期刊:
BIOMATERIALS
影响因子:
14
作者:
[Tuleuova, Nazgul, Lee, Ji Youn, Lee, Jennifer, Ramanculov, Erlan, Zern, Mark A., Revzin, Alexander]
通讯作者:
Revzin, Alexander
共 6 条
Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases
-
批准号:10736006
-
项目类别:
-
资助金额:$70.65万
-
财政年份:2023
-
负责人:Alexander Revzin
-
依托单位:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
-
批准号:9882916
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2020
-
负责人:Alexander Revzin
-
依托单位:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
-
批准号:10155447
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2020
-
负责人:Alexander Revzin
-
依托单位:
Context rich mass spectrometry of molecular localization and cellular interactions
-
批准号:9751908
-
项目类别:
-
资助金额:$47.88万
-
财政年份:2017
-
负责人:Alexander Revzin
-
依托单位:
Microsystems for Shaping Stem Cell Fate Selections
-
批准号:9215666
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2016
-
负责人:Alexander Revzin
-
依托单位:
Microsystems for Shaping Stem Cell Fate Selections
-
批准号:9889953
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2016
-
负责人:Alexander Revzin
-
依托单位:
Microsystems for Shaping Stem Cell Fate Selections
-
批准号:9412328
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2016
-
负责人:Alexander Revzin
-
依托单位:
Novel heterotypic cell cultures for liver toxicology studies
-
批准号:8323544
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2011
-
负责人:Alexander Revzin
-
依托单位:
Novel heterotypic cell cultures for liver toxicology studies
-
批准号:8054693
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2011
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8448619
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8066334
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8247791
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:8637982
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
-
批准号:7890296
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2010
-
负责人:Alexander Revzin
-
依托单位:
Microfabricated Biosensor Platform for Monitoring of Cell Metabolism
-
批准号:7471344
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2009
-
负责人:Alexander Revzin
-
依托单位:
Microfabricated Biosensor Platform for Monitoring of Cell Metabolism
-
批准号:7837694
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2009
-
负责人:Alexander Revzin
-
依托单位:
Microfabrication Tools for In Vitro Monitoring of Cancer Cell Metabolism
-
批准号:7366975
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2008
-
负责人:Alexander Revzin
-
依托单位:
Microfabrication Tools for In Vitro Monitoring of Cancer Cell Metabolism
-
批准号:7623951
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2008
-
负责人:Alexander Revzin
-
依托单位:
Effects of Microengineered Interactions on Liver-Specific Gene Expression
-
批准号:7150237
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2006
-
负责人:Alexander Revzin
-
依托单位:
海外基金